INCRELEX

Marca svizra · 529662 · Marca da pled · En vigur

Inscripziun en il register

Numer da registraziun
529662
Numer da la dumonda
03901/2004
Status
En vigur
Tip
Marca da pled
Deponida
19-11-2004
Registrada
17-01-2005
Publitgada
01-02-2005
Protegida fin ils
19-11-2034
Prioritad
21.05.2004 US
Lingua da la procedura
franzos
Funtauna
Swissreg

Products e servetschs

Pharmaceuticals

Préparations pharmaceutiques, vétérinaires, thérapeutiques et produits hygiéniques pour la médecine; produits et préparations pharmaceutiques à usage médical.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-09-2024

    Adressa dal possessur midada

    Owner
    Ipsen Biopharmaceuticals, Inc., 106 Allen Road, 3rd Floor, Basking Ridge, New Jersey 07920, USA → Ipsen Biopharmaceuticals, Inc., One Main Street, Cambridge, Massachusetts 02142, USA

    Published in Swissreg on 24.09.2024

  2. 20-09-2024

    Prolungà

    Expiry date
    19.11.2024 → 19.11.2034

    Published in Swissreg on 20.09.2024

  3. 10-12-2014

    Adressa midada

    Owner
    Tercica, Inc., 651 Gateway Boulevard,, Suite 950, South San Francisco (CA 94080), USA → Ipsen Biopharmaceuticals, Inc., 106 Allen Road, 3rd Floor, Basking Ridge, New Jersey 07920, USA

    Published in Swissreg on 10.12.2014

  4. 10-12-2014

    Prolungà

    Published in Swissreg on 10.12.2014

  5. 02-11-2010

    Adressa dal represchentant midada

    Representative
    KIRKER & Cie SA, Conseils en Marques, 122, rue de Genève,, Case postale 153, 1226 Thônex / Genève → Kirker & Cie SA, Conseils en Marques, Rue de Genève 122,, Case Postale 153, 1226 Thônex

    Published in Swissreg on 02.11.2010

  6. 01-02-2005

    Registrà

    Published in the SOGC no. 22 of 01.02.2005

Partidas

Il register numna mintga partida cun num ed adressa. Ina partida è colliada cun ina unitad, sch’exactamain ina unitad dal register da commerzi porta ses num; la via d’ina partida betg uschia renconuschida na vegn betg mussada qua.